Under pressure: New York clinics have reported a rise in demand for treatment for testosterone deficiency from Wall Street high-flyers
The male hormone testosterone has become an unlikely drug of choice for Wall Street traders seeking to give themselves an edge over their professional rivals.
New York clinics have reported a rise in treatment for ‘testosterone deficiency’, sometimes known as ‘andropause’.
They say many workers in the male-dominated industry are hoping that boosters of the hormone will help them perform better at work and put in longer hours.
Upper West Side osteopath Lionel Bissoon, who now specialises in ‘integrative medicine’, says he first noticed demand for testosterone replacement therapy when the financial crisis hit. Continue reading
Inside First 